ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024 [Yahoo! Finance]
ChromaDex Corporation (CDXC)
NASDAQ:AMEX Investor Relations:
investors.chromadex.com
Company Research
Source: Yahoo! Finance
aging, announced that it will hold a conference call on Wednesday, March 6, 2024 at 4:30 p.m. ET to discuss its financial results for the fourth quarter, which ended December 31, 2023. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call. Investor Conference Call: ChromaDex management will host an investor conference call to discuss fourth quarter 2023 results and provide a general business update on Wednesday, March 6, at 4:30 p.m. ET. Participants should call in at least 10 minutes prior to the call. The dial-in information is as follows: Date: Wednesday, March 6, 2024 Time: 4:30 p.m. ET (1:30 p.m. PT) Toll-free dial-in number: 1-888-596-4144 Conference ID: 8584242 Webcast link: ChromaDex Fourth Quarter 2023 Earnings Conference Call The conference call will be broadcast live and available for replay here and via the investor relations section of the Company's website a
Show less
Read more
Impact Snapshot
Event Time:
CDXC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXC alerts
High impacting ChromaDex Corporation news events
Weekly update
A roundup of the hottest topics
CDXC
News
- ChromaDex's NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement [Yahoo! Finance]Yahoo! Finance
- ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy SupplementBusiness Wire
- ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe® [Yahoo! Finance]Yahoo! Finance
- ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®Business Wire
- ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 [Yahoo! Finance]Yahoo! Finance
CDXC
Earnings
- 3/6/24 - Beat
CDXC
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- CDXC's page on the SEC website